PATHWAYS FOR RARE AND ORPHAN STUDI… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

ELLEN MORGAN

Phone

7605331884

Tax Period

2023-01-01 to 2023-12-31

PATHWAYS FOR RARE AND ORPHAN STUDIES, founded in 2011, is a micro nonprofit in the Health Care sector that reported $44 in total revenue in fiscal year 2023. Revenue fell 94% from the prior year — a significant decline worth monitoring. Expenses of $8K exceeded revenue, resulting in a 17714% operating deficit.

Mission

DEDICATED TO CONDUCTING CLINICAL TRIALS FOR DISEASES THAT EFFECT THE POOREST PEOPLE IN DEVELOPING COUNTRIES

Program Service Accomplishments

Program 1

Expenses: $7,838 Revenue: $44

CONDUCTING CLINICAL TRIALS FOR DISEASES THAT EFFECT THE POOREST PEOPLE IN DEVELOPING COUNTRIES

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $44

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $44

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $7,838

Other Expenses $7,838

TOTAL EXPENSES $7,838

Year-over-Year Comparison

	2023	2022	Change
Revenue	$44	$795	-0.9%
Expenses	$7,838	$9,255	-0.2%
Net Income	$-7,794	$-8,460	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELLEN MORGAN	President	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$44	$7,838	$482,110	$-7,794
2022	$795	$9,255	$489,878	$-8,460
2021	$10,926	$25,811	$501,714	$-14,885
2020	$550,658	$48,456	$519,316	$502,202

PATHWAYS FOR RARE AND ORPHAN STUDIES